What happens when clinical trial data moves faster, but patient progression does not?

AI is helping sponsors improve data review, endpoint assessment, and operational decision-making. But faster trial intelligence does not automatically solve patient qualification, readiness, or drop-off before screening.

That gap creates slower enrollment, higher site burden, wasted recruitment spend, and delayed screening momentum.

This whitepaper explores why AI-enabled trials still need a stronger human + digital activation pathway to move the right patients forward. 

See how 83bar combines digital pre-screening, clinical contact center validation, patient education, and site-ready handoff to help sponsors activate better-qualified patients before sites inherit the burden.